Thermo Fisher logo

TMOThermo Fisher

Pharma & Healthcare · US · Thermo Fisher Scientific Inc.

3 of 6 ratios computed · receipts verified server-side

Idiot Index
50
out of 100 · 3/6 ratios · FY 2023

The full receipt

Latest published value for each ratio, with the sector median for context and year-over-year change where the prior year is available.

  • Markup

    How much revenue per dollar of cost.

    Not computed: missing input.
    Needed but not in this company's XBRL filings: Cost of Goods Sold.
    What this company did disclose: Stock Buybacks, CEO Total Compensation, Dividends Paid, Median Employee Compensation, Net Income, Operating Expenses, R&D Expense, Revenue
  • Operational Markup

    Revenue per dollar of cost + operating expenses. The multiplier after legitimate operations.

    Not computed: missing input.
    Needed but not in this company's XBRL filings: Cost of Goods Sold.
    What this company did disclose: Stock Buybacks, CEO Total Compensation, Dividends Paid, Median Employee Compensation, Net Income, Operating Expenses, R&D Expense, Revenue
  • Labor Share

    How much of every revenue dollar reaches workers.

    Not computed: missing input.
    Needed but not in this company's XBRL filings: Total Employee Compensation.
    What this company did disclose: Stock Buybacks, CEO Total Compensation, Dividends Paid, Median Employee Compensation, Net Income, Operating Expenses, R&D Expense, Revenue
  • Executive Extraction

    How many times a CEO out-earns the median employee.

    260.8× CEO / median workerverified
    CEO earns 261× the median worker
    Sector median: 263.0Median range for extraction in sector
    FY 2023v1.0.0
  • Shareholder Extraction

    Dollars sent to shareholders for every dollar invested in R&D.

    1.7034× buybacks+dividends / R&Dverified
    $1.70 to shareholders for every $1 in R&D
    Sector median: 0.7492Top 24% for extraction in sector
    FY 2023v1.0.0
  • Capital Extraction

    How much of net profit goes to shareholders rather than back into the business.

    0.3099× buybacks+dividends / net incomeverified
    31% of net profit returned to shareholders, 69% reinvested
    Sector median: 0.5294Median range for extraction in sector
    FY 2023v1.0.0

Company response

No verified response yet. If you represent Thermo Fisher, you can add context, agree, or dispute.

Source data

Every raw line item this company disclosed in its XBRL filings. Click any filing to view the original on SEC.gov.

FY 2023· 8 facts
ConceptValueUnitPeriodFilingReceipt
CEO Total Compensation
CEOTotalCompensation
18,976,669USDFY0001193125-24-090173verified
Dividends Paid
PaymentsOfDividendsCommonStock
395,000,000USDFY0000097745-24-000007verified
Median Employee Compensation
MedianEmployeeCompensation
72,762USDFY0001193125-24-090173verified
Net Income
ProfitLoss
7,728,000,000USDFY0000097745-24-000007verified
Operating Expenses
OperatingExpensesDerived(sum:SellingGeneralAndAdministrativeExpense+ResearchAndDevelopmentExpense)
9,413,000,000USDFY0000097745-24-000007verified
R&D Expense
ResearchAndDevelopmentExpense
1,406,000,000USDFY0000097745-24-000007verified
Revenue
RevenueFromContractWithCustomerExcludingAssessedTax
39,211,000,000USDFY0000097745-24-000007verified
Stock Buybacks
PaymentsForRepurchaseOfCommonStock
2,000,000,000USDFY0000097745-24-000007verified